Gencor reports that a new study that has been submitted for publication found that its proprietary fenugreek extract, Testofen, increased strength, endurance, and lean body mass is healthy, active males.
Photo © iStockphoto.com
A new unpublished study shows that Gencor’s (Irvine, CA) proprietary fenugreek extract (Testofen) increases strength, aerobic endurance, and lean body mass in healthy, active men. The double-blind, randomized, dose response, eight-week clinical trial was conducted at RDC Global with 138 healthy, non-smoking male subjects, and examined changes in lean body mass, fat mass, upper and lower body muscular strength, and endurance. Results showed that the extract acted in a dose-response manner, with 600 mg per day of Testofen in conjunction with an effective exercise routine demonstrating superior positive effects when compared to placebo, or 300 mg of Testofen per day.
“These significant and positive results show that Testofen may be an effective ergogenic aid for those wanting to rapidly improve their exercise performance and body composition above and beyond exercise training only,” said Chase Shryoc, vice president of sales and business development for Gencor, in a press release. “We are thrilled about the results of this study and look forward to incorporating Testofen into its next sports nutrition product.”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.